Potrero Capital Research’s Hinge Health HNGE Stock Holding History

Potrero Capital Research’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-117,162	Closed	-$4.52M	–	52
2026 Q1	$4.52M	Buy	+117,162	New	+$4.87M	2.77%	15

Other funds holding HNGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

12CM

11.2 Capital Management Las Vegas, Nevada $205M AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Potrero Capital Research's HNGE Position: Q2 2026 in Review

Potrero Capital Research sold out of Hinge Health (HNGE) in Q2 2026, closing a stake of 117,162 shares — an estimated $4.52M sold.

Potrero Capital Research first reported a position in HNGE in Q1 2026 and held it in 1 quarter. The position peaked at $4.52M in Q1 2026. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

Potrero Capital Research reported no remaining Hinge Health position as of Q2 2026 after selling out during the quarter.
Potrero Capital Research sold 117,162 Hinge Health shares in Q2 2026, an estimated $4.52M.
Potrero Capital Research first reported a position in Hinge Health in Q1 2026 and held it in 1 quarter.
Potrero Capital Research's Hinge Health position peaked at $4.52M in Q1 2026.
276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Potrero Capital Research's 13F filing for Q2 2026, filed 14 Aug 2026.